U.S., Oct. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07859839) titled 'Gabapentin vs. Benzonatate vs. Standard of Care for Cough in ILD' on Sept. 30.
Brief Summary: Absence of a clear standard of care and approved drug for chronic cough, the commonest symptom in ILD, calls for further research in this area. In this study, we aim to compare gabapentin and benzonatate treatment with the standard of care for treating chronic cough in ILD. We hypothesized that both gabapentin and benzonatate will be more effective than standard of care in treating chronic cough in ILD.
Study Start Date: Oct. 07
Study Type: INTERVENTIONAL
Condition:
Interstitial Lung Disease
Intervention:
DRUG: Gabapentin
Gabapentin a...